Your browser doesn't support javascript.
loading
An Unusual Case of Delirium after Restarting Clozapine.
Khanra, Sourav; Sethy, Rati Ranjan; Munda, Sanjay Kumar; Khess, Christoday Raja Jayant.
Afiliação
  • Khanra S; Department of Psychiatry, ICARE Institute of Medical Sciences and Research, Haldia, India.
  • Sethy RR; Department of Psychiatry, Institute of Medical Sciences & SUM Hospital, Bhubaneswar, India.
  • Munda SK; Department of Psychiatry, Central Institute of Psychiatry, Ranchi, India.
  • Khess CR; Department of Psychiatry, Central Institute of Psychiatry, Ranchi, India.
Clin Psychopharmacol Neurosci ; 14(1): 107-8, 2016 Feb 29.
Article em En | MEDLINE | ID: mdl-26792049
Clozapine is a gold standard medication and drug of choice in refractory schizophrenia. Among many of its fatal side effects, delirium is less reported and inconsistently recognized by clinicians. We here present a case of delirium which emerged during retreatment with clozapine in a patient of paranoid schizophrenia. A patient diagnosed with paranoid schizophrenia, was restarted on clozapine after he left medications and became symptomatic. He was delirious on 22nd day after clozapine was restarted. Clozapine was stopped and the patient was managed with standard treatment for delirium. After one week interval, clozapine was restarted. Delirium was not noted till 6 weeks of his hospital stay. Clozapine induced central anticholinergic toxicity or clozapine induced seizure might cause delirium in index case. Limited literature exist delirium with clozapine. Clinicians must have high index of suspicion to detect delirium during clozapine therapy. More researches should focus to explore the association between delirium and clozapine.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Clin Psychopharmacol Neurosci Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Clin Psychopharmacol Neurosci Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Índia